Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tafluprost (S01Ee05) As Part Of A So-Called Open House Model.

AOK RHEINLAND-PFALZ SAARLAND - DIE GESUNDHEITSKASSE Germany has Released a tender for Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tafluprost (S01Ee05) As Part Of A So-Called Open House Model. in Healthcare and Medicine. The tender was released on Apr 17, 2024.

Country - Germany

Summary - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tafluprost (S01Ee05) As Part Of A So-Called Open House Model.

Deadline - Mar 31, 2026

GT reference number - 81002907

Product classification - Medical equipments, pharmaceuticals and personal care products